Predictive significance of the proportion of ER-positive or PgR-positive tumor cells in response to neoadjuvant chemotherapy for operable HER2-negative breast cancer

By          

Experimental and Therapeutic Medicine, Vol. 3, Iss. 1, 2012-01 ,pp. : 66-71

Spandidos Publications

Access to resources Recommend Favorite

HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer

By Tulbah Asma   Ibrahim Ezzeldin   Ezzat Adnan   Ajarim Dahish   Rahal Mohammed   Weshi Amr   Sorbris Ralph  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 15-23

Humana Press, Inc

Access to resources Recommend Favorite

Efficacy of TCH/TEC neoadjuvant chemotherapy for the treatment of HER2overexpressing breast cancer

By            

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1922-1926

Spandidos Publications

Access to resources Recommend Favorite

Early prediction of response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and gray-scale ultrasonography

By Iwasa Hitomi   Kubota Kei   Hamada Norihiko   Nogami Munenobu   Nishioka Akihito  

Oncology Reports, Vol. 31, Iss. 4, 2014-04 ,pp. : 1555-1560

Spandidos Publications

Access to resources Recommend Favorite

RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy

By Denkert C.   Loibl S.   Kronenwett R.   Budczies J.   von Trne C.   Nekljudova V.   Darb-Esfahani S.   Solbach C.   Sinn B. V.   Petry C.   Mller B. M.   Hilfrich J.   Altmann G.   Staebler A.   Roth C.   Ataseven B.   Kirchner T.   Dietel M.   Untch M.   von Minckwitz G.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 632-639

Oxford University Press

Access to resources Recommend Favorite